Hermes Biomaterials
Ames
About Hermes Biomaterials
Hermes Biomaterials provides cutting-edge technology solutions to improve gene editing and transformation in plant cells. It focuses on biolistic delivery and offers new devices and solutions to dramatically increase delivery efficiency, resulting in superior seeds and biofuel crop
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Last round: Grant (Jan 2024)
- Website: hermesbiomat.com
- Phone: [email protected]
Industries & Categories
Agriculture, Farming
Canonical: https://fsome.com/organization/hermes-biomaterials-125718 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.